U.S. Markets closed

Lupin Limited (LUPIN.NS)

NSE - NSE Real Time Price. Currency in INR
Add to watchlist
1,110.20-2.35 (-0.21%)
At close: 3:30PM IST

Lupin Limited

Laxmi Towers, B Wing
5th Floor
Mumbai 400051
91 22 6640 2222

IndustryDrugs - Generic
Full Time Employees

Key Executives

Dr. Desh Bandhu GuptaFounder and Chairman447.79MN/AN/A
Mrs. Vinita D. GuptaChief Exec. Officer and Exec. Director190.17MN/A49
Dr. Kamal Kishore Sharm B.Eng (Chem) Ph.D.Vice Chairman133.02MN/A68
Mr. Nilesh D. GuptaManaging Director and Exec. Director75.91MN/AN/A
Mr. Ramesh SwaminathanChief Financial Officer and Exec. Director20.83MN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.


Lupin Limited, a pharmaceutical company, develops, manufactures, and markets a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) in India and internationally. It offers formulations for use in the areas of cardiology, central nervous system (CNS), diabetes, anti-asthma, gastro- intestinal, COPD, and gynecology; and APIs for use in therapeutic areas of cephalosporins, cardiovascular, and anti-TB. The company also develops drug delivery technologies; and biosimilars for various therapeutic indications, such as oncology, anti-inflammatory, anti-virals, rheumatoid arthritis, endocrinology, diabetes, ophthalmology, and women’s health. In addition, it engages in the novel drug discovery and development programs for use in the treatment of CNS disorders, oncology, immunology, pain and inflammation, and metabolic disorders. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is based in Mumbai, India.

Corporate Governance

Lupin Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.